This content is from: Premium Averill Partners Is Up 275 Percent in Two Years The top-performing hedge fund specializes in an unlikely part of the market. By Stephen Taub May 25, 2022
This content is from: Premium Life Sciences Funds Continue to Struggle in 2022 Most were down by double-digits in the first quarter. By Stephen Taub April 18, 2022
This content is from: Premium A New Biotech Fund for Suvretta Averill will be completely separate from Suvretta’s existing funds but share the firm’s infrastructure. By Stephen Taub February 21, 2020
This content is from: Premium Suvretta Revamps Holdings in Bid to Erase First Loss Five of the hedge fund firm’s nine largest long bets are new positions. By Steve Taub May 28, 2019
This content is from: Premium Suvretta’s Big Changes Pay Off The hedge fund headed by Aaron Cowen has gotten good results from the heavy revamping of its entire portfolio. By Stephen Taub July 22, 2019
This content is from: Premium Hedge Fund Suvretta Slashed Exposure in October The long-short fund raised cash and lowered its gross exposure amid the October selloff, preventing a big loss from being much worse. By Stephen Taub November 28, 2018
